The House of Lords Science and Technology Committee takes a further evidence session for its inquiry on Life Sciences and the Industrial Strategy.
Tuesday 13 March in Committee Room 4A, Palace of Westminster
- Professor Tony Young PhD, National Clinical Director, Innovation NHS England
- Much of the evidence we have received says that the NHS is often poor at adopting new innovations. Why is this and what can be done to improve the situation?
- What are the challenges in implementing the Accelerated Access Review and the benefits of doing so? What happens if it is not implemented?
- The Life Sciences Strategy sets out ambitions for the use of patient data. Is the NHS ready for this level of innovation in patient data?